Good responses but high TRM in adult patients after MSC therapy for GvHD

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Bone Marrow Transplantation

• Publication date

  2017-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1038/bmt.2016.317PMID 27941780
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Survival after mesenchymal stromal cell therapy in steroid-refractory acute graft-versus-host disease: systematic review and meta-analysis.

  2016cited by this paper
• Mesenchymal Stromal Cells for Treatment of Acute Steroid‐Refractory Graft Versus Host Disease: Clinical Responses and Long‐Term Outcome

  2016cited by this paper
• Efficacy of Mesenchymal Stem Cell Therapy for Steroid-Refractory Acute Graft-Versus-Host Disease following Allogeneic Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis

  2015cited by this paper
• Mesenchymal Stromal Cells for Treatment of Acute Steroid-Refractory GvHD: Clinical Responses and Long-Term Outcome.

  2015cited by this paper
• A robust and reproducible animal serum-free culture method for clinical-grade bone marrow-derived mesenchymal stromal cells

  2015cited by this paper
• Improved accuracy of acute graft-versus-host disease staging among multiple centers.

  2014cited by this paper
• Multiple infusions of mesenchymal stromal cells induce sustained remission in children with steroid‐refractory, grade III–IV acute graft‐versus‐host disease

  2013cited by this paper
• Fetal Membrane Cells for Treatment of Steroid‐Refractory Acute Graft‐Versus‐Host Disease

  2013cited by this paper
• First- and second-line systemic treatment of acute graft-versus-host disease: recommendations of the American Society of Blood and Marrow Transplantation.

  2012cited by this paper
• Graft-versus-host disease treatment: predictors of survival.

  2010cited by this paper
• Graft-versus-host disease.

  2009cited by this paper
• Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study.

  2008cited by this paper
• Prospective evaluation of 2 acute graft-versus-host (GVHD) grading systems: a joint Société Française de Greffe de Moëlle et Thérapie Cellulaire (SFGM-TC), Dana Farber Cancer Institute (DFCI), and International Bone Marrow Transplant Registry (IBMTR) prospective study.

  2005cited by this paper
• National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group report.

  2005cited by this paper
• CLINICAL MANIFESTATIONS OF GRAFT‐VERSUS-HOST DISEASE IN HUMAN RECIPIENTS OF MARROW FROM HL‐A-MATCHED SIBLING DONOR,S

  1974cited by this paper

• Mesenchymal Stem/Stromal Cells: A Review for Its Use After Allogeneic Hematopoietic Stem Cell Transplantation

  2026cites this paper
• Tumor Necrosis Factor Receptor 1 Is Required for Human Umbilical Cord–Derived Mesenchymal Stem Cell–Mediated Rheumatoid Arthritis Therapy

  2025cites this paper
• Mesenchymal stromal cells in management of steroid refractory acute graft vesrus host disease, systematic review and meta-analysis

  2025cites this paper
• Therapeutic impact of mesenchymal stem cells on idiopathic pneumonia syndrome after allogeneic hematopoietic stem cell transplantation

  2025cites this paper
• Mesenchymal stromal cells for steroid-refractory biopsy-proven grade III-IV acute Graft-versus-Host Disease with predominant gastrointestinal involvement

  2025cites this paper
• Mesenchymal Stem Cell Applications in Graft Versus Host Disease

  2024cites this paper
• Current advancements in nanotechnology for stem cells

  2024cites this paper
• Human umbilical cord-derived mesenchymal stromal cells for the treatment of steroid refractory grades III-IV acute graft-versus-host disease with long-term follow-up

  2024cites this paper
• International Society for Cell and Gene Therapy Clinical Translation Committee recommendations on mesenchymal stromal cells in graft-versus-host disease: easy manufacturing is faced with standardizing and commercialization challenges

  2024cites this paper
• Placenta-Derived Decidua Stromal Cells: A New Frontier in the Therapy of Acute Graft-Versus-Host Disease

  2024cites this paper
• International society for cell & gene therapy stem cell engineering committee: Cellular therapies for the treatment of graft-versus-host-disease after hematopoietic stem cell transplant.

  2023cites this paper
• Translating mesenchymal stem cell and their exosome research into GMP compliant advanced therapy products: Promises, problems and prospects

  2023cites this paper
• Understanding and treatment of cutaneous graft-versus-host-disease

  2023cites this paper
• Current perspectives on mesenchymal stromal cell therapy for graft versus host disease

  2023influential citation
• The efficiency of human umbilical cord mesenchymal stem cells as a salvage treatment for steroid-refractory acute graft-versus-host disease

  2023cites this paper
• Current status of clinical trials assessing mesenchymal stem cell therapy for graft versus host disease: a systematic review

  2022cites this paper
• Insights into mechanisms of graft-versus-host disease through humanised mouse models

  2022cites this paper
• Menstrual blood-derived mesenchymal stromal cells efficiently ameliorate experimental autoimmune encephalomyelitis by inhibiting T cell activation in mice

  2022cites this paper
• Mesenchymal Stromal Cells for Treating Steroid-Resistant Acute and Chronic Graft Versus Host Disease: A Multicenter Compassionate Use Experience

  2022cites this paper
• Mesenchymal Stromal Cells for Enhancing Hematopoietic Engraftment and Treatment of Graft-Versus-Host Disease, Hemorrhages and Acute Respiratory Distress Syndrome

  2022cites this paper
• Optimizing Blood Stem Cell Transplants Through Cellular Engineering

  2022cites this paper
• Efficacy and safety of mesenchymal stem cells treatment for multidrug-resistant graft-versus-host disease after haploidentical allogeneic hematopoietic stem cell transplantation

  2022cites this paper
• Mesenchymal Stromal Cells for the Treatment of Graft Versus Host Disease

  2021cites this paper
• Potential Use of Mesenchymal Multipotent Cells for Hemopoietic Stem Cell Transplantation: Pro and Contra

  2021cites this paper
• Chondrogenic differentiation of human bone marrow-derived mesenchymal 1 stromal cells in a three-dimensional environment 2 3 Running title : Chondrogenic differentiation MSCs in 3 D 4 5

  2021cites this paper
• A Large-Scale Bank of Organ Donor Bone Marrow and Matched Mesenchymal Stem Cells for Promoting Immunomodulation and Transplant Tolerance

  2021cites this paper
• Efficiency of human monocyte-derived suppressor cell-based treatment in graft-versus-host disease prevention while preserving graft-versus-leukemia effect

  2021cites this paper
• Metabolic Reprogramming of GMP Grade Cord Tissue Derived Mesenchymal Stem Cells Enhances Their Suppressive Potential in GVHD

  2021cites this paper
• Role of ex vivo Expanded Mesenchymal Stromal Cells in Determining Hematopoietic Stem Cell Transplantation Outcome

  2021cites this paper
• Cell therapy in transplantation: A comprehensive review of the current applications of cell therapy in transplant patients with the focus on Tregs, CAR Tregs, and Mesenchymal stem cells.

  2021cites this paper
• Off-the-shelf bone marrow-derived mesenchymal stem cell treatment for acute graft-versus-host disease: real-world evidence

  2021cites this paper
• Mesenchymal stem cells (MSC) delays the occurrence of graft-versus-host disease(GVHD) in the inhibition of hematopoietic stem cells in major histocompatibility complex semi-consistent mice by regulating the expression of IFN-γ/IL-6

  2021cites this paper
• Treatment of Steroid-Refractory Acute Graft-Versus-Host Disease Using Commercial Mesenchymal Stem Cell Products

  2021cites this paper
• Extended Treatment With Mesenchymal Stromal Cells-Frankfurt am Main (MSC-FFM, Obnitix) in a Pediatric Patient With Steroid-refractory Acute Gastrointestinal Graft-Versus-Host Disease (GVHD): Case Report and Review of the Literature.

  2020cites this paper
• Mesenchymal stromal cells for the prophylaxis and treatment of graft-versus-host disease—a meta-analysis

  2020influential citation
• Mesenchymal stromal cells in hematopoietic cell transplantation.

  2020cites this paper
• Mesenchymal stromal cells for osteonecrosis

  2020cites this paper
• Mesenchymal Stromal Cells in Pediatric Hematopoietic Cell Transplantation a Review and a Pilot Study in Children Treated With Decidua Stromal Cells for Acute Graft-versus-Host Disease

  2020cites this paper
• Human Mesenchymal Stromal Cell Secretome Promotes the Immunoregulatory Phenotype and Phagocytosis Activity in Human Macrophages

  2020cites this paper
• Mesenchymal Stromal Cells for Graft Versus Host Disease: Mechanism-Based Biomarkers

  2020cites this paper
• A genomic biomarker that identifies human bone marrow‐derived mesenchymal stem cells with high scalability

  2020cites this paper
• Associations of clinical outcomes and MRI findings in intra-articular administration of autologous adipose-derived stem cells for knee osteoarthritis

  2020cites this paper
• Mesenchymal stem cells: a promising way in therapies of graft-versus-host disease

  2020cites this paper
• Key Metabolic Pathways in MSC-Mediated Immunomodulation: Implications for the Prophylaxis and Treatment of Graft Versus Host Disease

  2020cites this paper
• The use of unlicensed bone marrow-derived platelet lysate-expanded mesenchymal stromal cells in colitis: a pre-clinical study.

  2019cites this paper
• Renin-angiotensin system in intestinal inflammation – experimental studies with therapeutic interventions

  2019cites this paper
• Children and Adults with Refractory Acute Graft-versus-Host Disease Respond to Treatment with the Mesenchymal Stromal Cell Preparation “MSC-FFM”—Outcome Report of 92 Patients

  2019cites this paper
• Clinical Translation of Mesenchymal Stromal Cell Therapy for Graft Versus Host Disease

  2019cites this paper
• Inpatient Management of Mucocutaneous GVHD

  2019cites this paper
• Chondrogenic differentiation of human bone marrow‐derived mesenchymal stromal cells in a three‐dimensional environment

  2019cites this paper
• The Utilization of Freezing Steps in Mesenchymal Stromal Cell (MSC) Manufacturing: Potential Impact on Quality and Cell Functionality Attributes

  2019influential citation
• Polyunsaturated fatty acids modify the extracellular vesicle membranes and increase the production of proresolving lipid mediators of human mesenchymal stromal cells.

  2019cites this paper
• HLA-DR expression in clinical-grade bone marrow-derived multipotent mesenchymal stromal cells: a two-site study

  2019cites this paper
• Clinical Use of Mesenchymal Stromal Cells in the Treatment of Acute Graft-versus-Host Disease

  2019cites this paper
• Immunomonitoring of MSC-Treated GvHD Patients Reveals Only Moderate Potential for Response Prediction but Indicates Treatment Safety

  2018cites this paper
• Automated image analysis detects aging in clinical-grade mesenchymal stromal cell cultures

  2018cites this paper
• Mesenchymale Stromazellen auf demWeg zur klinischen Anwendung : Update 2018 Mesenchymal Stromal Cells on Their Way from Bench to Bedside : Update 2018

  2018cites this paper
• International Forum on GMP‐grade human platelet lysate for cell propagation: summary

  2018cites this paper
• International Forum on GMP‐grade human platelet lysate for cell propagation

  2018cites this paper
• Mesenchymale Stromazellen auf dem Weg zur klinischen Anwendung: Update 2018

  2018cites this paper
• Effective treatment of steroid and therapy-refractory acute graft-versus-host disease with a novel mesenchymal stromal cell product (MSC-FFM)

  2018cites this paper
• In Vitro Cell Expansion and CTLA4 in Advanced T-Cell Therapies

  2017influential citation
• World Journal of Stem Cells

  year unknowncites this paper